Showing results (151-160 of 226) with videos related to
Sort By:
Pageof 23
NPJ Genomic Medicine|September 14, 2023
A pan-sarcoma landscape of telomeric content shows that alterations in RAD51B and GID4 are associated with higher telomeric contentRadwa Sharaf, Dexter X Jin, John Grady, et al.Cancer Research|November 4, 2005
An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug developmentCarleen Cullinane, Donna S Dorow, Maya Kansara, et al.The Oncologist|May 8, 2025
Real-world characteristics and survival outcomes of patients with metastatic ALK fusion-positive solid tumors treated with standard-of-care therapiesShirish M Gadgeel, Otto Fajardo, Fabrice Barlesi, et al.BMC Cancer|March 10, 2011
Integrated mutation, copy number and expression profiling in resectable non-small cell lung cancerGenni M Newnham, Matthew Conron, Sueanne McLachlan, et al.Cancer Research|September 3, 2009
Parathyroid hormone-related protein protects against mammary tumor emergence and is associated with monocyte infiltration in ductal carcinoma in situNicholas I Fleming, Melanie K Trivett, Joshy George, et al.Drug Discovery Today|October 24, 2015
Cancer 2015: a longitudinal whole-of-system study of genomic cancer medicineDavid M Thomas, Stephen Fox, Paula K Lorgelly, et al.Emergency Radiology|December 13, 2018
Evaluation of the proximal coronary arteries in suspected pulmonary embolism: diagnostic images in 51% of patients using non-gated, dual-source CT pulmonary angiographyDavid M Thomas, Patrick D McLaughlin, James P Nugent, et al.Journal of Neurochemistry|December 24, 2011
Mephedrone, an abused psychoactive component of 'bath salts' and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatumMariana Angoa-Pérez, Michael J Kane, Dina M Francescutti, et al.Clinical and Translational Medicine|April 17, 2024
Computational repurposing of oncology drugs through off-target drug binding interactions from pharmacological databasesImogen R Walpole, Farzana Y Zaman, Peinan Zhao, et al.Healthcare (Basel, Switzerland)|October 27, 2022
Effective and Efficient Delivery of Genome-Based Testing-What Conditions Are Necessary for Health System Readiness?Don Husereau, Lotte Steuten, Vivek Muthu, et al.Pageof 23